Abstract:High tissue TGF-beta1 quantity in healthy nasal mucosa without its active form on the cell surface and its low quantity in polyps may reflect its essential role in the inhibitory mechanisms of nasal polyposis. Interleukin-5 plays a key role in the eosinophil recruitment and activation, and both atopic and nonatopic pathways might activate this process. The main sources of IL-5 and TGF-beta1 are the eosinophils and macrophages. Immediate hypersensitivity, besides other mechanisms, might be related to atopic pol… Show more
“…Both latency-associated peptide (LAP) and latent TGF-β-binding protein (LTBP-1) play an important role in the regulation of TGF-β1 by preventing it from exerting its biological functions [9,10]. This repression is important for maintaining normal mucosal structure, as evidenced by the presence of only a few active TGF-β1 proteins but a substantial amount of nonactive protein in healthy mucosa [11]. However, a significant increase in the active form can be detected in patients with CRS, indicating that the activation of TGF-β1 is out of control and is involved in the tissue remodeling process of CRS [12].…”
Section: The Dysregulated Activation Of Tgf-β1mentioning
Transforming growth factor-β1 (TGF-β1) plays a key role in the tissue remodeling processes involved in chronic rhinosinusitis (CRS), with the biological functions of secreted TGF-β1 regulated by multiple proteins. Among these regulators, latency-associated peptide and latent TGF-β-binding protein inhibit TGF-β1 function, whereas different proteases and integrins activate it. Progress in understanding the factors responsible for the bioactivity and expression of TGF-β1 has revealed that the dysregulation of TGF-β1 activation and expression is closely associated with the chronic respiratory inflammatory diseases involved in CRS. This review of the regulation of TGF-β1 activation and expression provides insight into the mechanism responsible for the different CRS subtypes, which will help further the investigation of novel therapy targets for the treatment of CRS.
“…Both latency-associated peptide (LAP) and latent TGF-β-binding protein (LTBP-1) play an important role in the regulation of TGF-β1 by preventing it from exerting its biological functions [9,10]. This repression is important for maintaining normal mucosal structure, as evidenced by the presence of only a few active TGF-β1 proteins but a substantial amount of nonactive protein in healthy mucosa [11]. However, a significant increase in the active form can be detected in patients with CRS, indicating that the activation of TGF-β1 is out of control and is involved in the tissue remodeling process of CRS [12].…”
Section: The Dysregulated Activation Of Tgf-β1mentioning
Transforming growth factor-β1 (TGF-β1) plays a key role in the tissue remodeling processes involved in chronic rhinosinusitis (CRS), with the biological functions of secreted TGF-β1 regulated by multiple proteins. Among these regulators, latency-associated peptide and latent TGF-β-binding protein inhibit TGF-β1 function, whereas different proteases and integrins activate it. Progress in understanding the factors responsible for the bioactivity and expression of TGF-β1 has revealed that the dysregulation of TGF-β1 activation and expression is closely associated with the chronic respiratory inflammatory diseases involved in CRS. This review of the regulation of TGF-β1 activation and expression provides insight into the mechanism responsible for the different CRS subtypes, which will help further the investigation of novel therapy targets for the treatment of CRS.
“…Eosinophils are sources of interleukins that bear autocrine and modulator effect on the function of other cells 14 . The continuity of the inflammatory response seen in the eosinophylic NSP is related to cytokines such as IL5 and GM-CSF which increase survival and reduce the eosinophil apoptosis rate 7,8,[10][11][12] . Therefore, they regulate proliferation and cell ac- tivation, broadening local immune response and polyp formation.…”
Section: Discussionmentioning
confidence: 99%
“…They also bear morphologic alterations such as nasal membrane hyperplasia, irregularity of gland distribution, squamous metaplasia and edema ( Figure 2) 3,4 . Although it has been related to IgE mediated hypersensitivity, or nasal allergy, studies have shown that allergy is only one possible cause or a contributing factor [5][6][7] . Eosinophil and polyp structural cells secrete cytokines that maintain the inflammation process and the Eosinophil build up constant.…”
Eosi nophilic nasosinusal polyposis is a chronic inflammatory infection with elevated infiltration of eosinophils, which presents high rate of recurrence after surgical treatment. The continuous inflammatory process that leads to the formation of polyps requires constant clinical treatment. Contributing to the maintenance of eosinophilia are cytokines IL5 (interleukin-5) and GM-CSF (granulocyte macrophages colony-stimulating factor), which show up in elevated concentrations. These oligoproteins diminish the rate of apoptosis and prolong the survival of eosinophils. Aim: By diminishing these cytokines, the action of Mitomycin C (MMC), an antineoplasic drug which inhibits the synthesis of DNA, was studied. In a recent study the power of this drug to cause apoptosis in eosinophils, in vitro, of nasal polyps was verified. Methodology: A biopsy of the nasal polyps was undertaken in 15 patients carriers of eosinophilic nasosinusal polyposis 24 hours after applying 0.5 mg/ml of MMC during five minutes. RT-PCR (reverse transcription of polymerase chain reaction) for IL5 and GM-CSF was the method used to obtain the results. Results: The comparison of the results of GM-CSF pre-and post-application of MMC, when the paired T-test was used, showed p=0.041 and for IL5 we found p<0.001. Conclusion: Topic use of MMC in patients with eosinophilic nasosinusal polyposis shows statistically significant reduction for GM-CSF and significant and important reduction for IL5.
“…and chemokines (eotaxin, RANTES) are involved in this process. IL-5, an important factor in eosinophilic inflammation, is higher in nasal polyp than in healthy mucosa [2,3].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.